Mirae Asset Global Investments
INDP icon

Mirae Asset Global Investments’s Indaptus Therapeutics INDP Stock Holding History

Mirae Asset Global Investments’s Portfolio INDP Stock Details INDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-260
Closed -$2.53M – 1447
2019
Q2 		$2.53M Buy
+260
New +$3.28M 0.02% 636

Other funds holding INDP

MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Mirae Asset Global Investments's INDP Position: Q3 2019 in Review

Mirae Asset Global Investments sold out of Indaptus Therapeutics (INDP) in Q3 2019, closing a stake of 260 shares — an estimated $2.53M sold.

Mirae Asset Global Investments first reported a position in INDP in Q2 2019 and held it in 1 quarter. The position peaked at $2.53M in Q2 2019. 33 funds tracked by Wall St. Rank hold INDP as of Q3 2019.

  • Mirae Asset Global Investments reported no remaining Indaptus Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Mirae Asset Global Investments sold 260 Indaptus Therapeutics shares in Q3 2019, an estimated $2.53M.
  • Mirae Asset Global Investments first reported a position in Indaptus Therapeutics in Q2 2019 and held it in 1 quarter.
  • Mirae Asset Global Investments's Indaptus Therapeutics position peaked at $2.53M in Q2 2019.
  • 33 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q3 2019.

Based on Mirae Asset Global Investments's 13F filing for Q3 2019, filed 12 Nov 2019.